AVITA Medical (RCEL) News Today $8.65 +0.11 (+1.29%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period AVITA Medical, Inc. (NASDAQ:RCEL) Holdings Boosted by Barclays PLCBarclays PLC grew its stake in shares of AVITA Medical, Inc. (NASDAQ:RCEL - Free Report) by 340.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 37,503 shares of the company's stock after purchasing an additional 28,979January 19 at 3:03 AM | marketbeat.comShort Interest in AVITA Medical, Inc. (NASDAQ:RCEL) Rises By 25.9%AVITA Medical, Inc. (NASDAQ:RCEL - Get Free Report) was the recipient of a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 1,460,000 shares, an increase of 25.9% from the December 15th total of 1,160,000 shares. Currently, 5.9% of the company's shares are short sold. Based on an average daily volume of 132,500 shares, the short-interest ratio is currently 11.0 days.January 18 at 8:51 PM | marketbeat.comInvestors Burned By AVITA Medical's Sales Miss: I'm Even More BullishJanuary 12, 2025 | seekingalpha.comAVITA Medical's (RCEL) "Buy" Rating Reaffirmed at D. Boral CapitalJanuary 11, 2025 | americanbankingnews.comAVITA Medical: A Dip Buy As 2025 Looks Bullish With Cohealyx And RECELL GO MiniJanuary 10, 2025 | seekingalpha.comAvita Medical price target lowered to $14 from $20 at Lake StreetJanuary 10, 2025 | markets.businessinsider.comAVITA Medical, Inc. (RCEL): A Bull Case TheoryJanuary 9, 2025 | insidermonkey.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: CAMP4 Therapeutics Corporation (CAMP) and Avita Medical (RCEL)January 8, 2025 | markets.businessinsider.comCantor Fitzgerald Sticks to Its Buy Rating for Avita Medical (RCEL)January 8, 2025 | markets.businessinsider.comAvita Medical Cuts Annual Sales Forecast On Softer Demand From HospitalsJanuary 8, 2025 | benzinga.comAVITA Medical (NASDAQ:RCEL) Price Target Cut to $14.00 by Analysts at Lake Street CapitalLake Street Capital reduced their price objective on shares of AVITA Medical from $20.00 to $14.00 and set a "buy" rating on the stock in a research note on Wednesday.January 8, 2025 | marketbeat.comAVITA Medical (NASDAQ:RCEL) Receives "Buy" Rating from D. Boral CapitalD. Boral Capital restated a "buy" rating and set a $25.00 price objective on shares of AVITA Medical in a research report on Wednesday.January 8, 2025 | marketbeat.comAVITA Medical stock slides 14% on lowered guidanceJanuary 8, 2025 | msn.comAVITA Medical's shares sink 19% after another forecast cutJanuary 7, 2025 | reuters.comAVITA Medical Updates Expected Fourth Quarter and Full Year 2024 Revenue, Provides 2025 Financial GuidanceJanuary 7, 2025 | globenewswire.comAVITA Medical Just Tripled Its TAM In The Burn MarketJanuary 2, 2025 | seekingalpha.comCantor Fitzgerald bullish on Avita Medical after FDA approval for RECELL GO MiniDecember 25, 2024 | finance.yahoo.comAvita Medical initiated with a Buy at D. Boral CapitalDecember 25, 2024 | markets.businessinsider.comLake Street Reaffirms Their Buy Rating on Avita Medical (RCEL)December 25, 2024 | markets.businessinsider.comD. Boral Capital Initiates Coverage of AVITA Medical (RCEL) with Buy RecommendationDecember 25, 2024 | msn.comAVITA Medical (NASDAQ:RCEL) Stock Quotes, Forecast and News SummaryDecember 24, 2024 | benzinga.comCantor Fitzgerald Reiterates "Overweight" Rating for AVITA Medical (NASDAQ:RCEL)Cantor Fitzgerald restated an "overweight" rating and issued a $21.00 price objective on shares of AVITA Medical in a report on Tuesday.December 24, 2024 | marketbeat.comAVITA Medical (NASDAQ:RCEL) Earns Buy Rating from Analysts at D. Boral CapitalD. Boral Capital began coverage on AVITA Medical in a research report on Tuesday. They set a "buy" rating and a $25.00 price target on the stock.December 24, 2024 | marketbeat.comAvita Medical discloses FDA premarket approval for ECELL GO miniDecember 24, 2024 | markets.businessinsider.comAvita gets FDA approval for RECELL GO miniDecember 24, 2024 | msn.comAVITA Medical Announces FDA Approval of RECELL GO mini, Optimizing Treatment for Smaller WoundsDecember 23, 2024 | globenewswire.comLake Street Gives a Buy Rating to Avita Medical (RCEL)December 20, 2024 | markets.businessinsider.comAVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable MarketDecember 19, 2024 | globenewswire.comAVITA Medical to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 18, 2024 | globenewswire.comPILLAR partners with Avita Pharmacy to enhance health care servicesDecember 18, 2024 | msn.comDavid D. O'toole Buys 975 Shares of AVITA Medical, Inc. (NASDAQ:RCEL) StockDecember 6, 2024 | insidertrades.comAVITA Medical, Inc. (RCEL): A Bull Case TheoryNovember 30, 2024 | insidermonkey.comAVITA Medical's SWOT analysis: regenerative medicine firm's stock faces growth hurdlesNovember 27, 2024 | investing.comAVITA Medical to Present at the Piper Sandler 36ᵗʰ Annual Healthcare ConferenceNovember 26, 2024 | markets.businessinsider.comAVITA Medical to Present at the Piper Sandler 36ᵗʰ Annual Healthcare ConferenceNovember 25, 2024 | globenewswire.comAVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New ZealandNovember 12, 2024 | globenewswire.comAVITA Medical, Inc. (NASDAQ:RCEL) Third-Quarter Results: Here's What Analysts Are Forecasting For Next YearNovember 9, 2024 | finance.yahoo.comAVITA Medical, Inc. (RCEL) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comAVITA Medical's (RCEL) Neutral Rating Reiterated at Piper SandlerPiper Sandler reaffirmed a "neutral" rating and issued a $12.00 target price (up from $9.00) on shares of AVITA Medical in a research note on Friday.November 8, 2024 | marketbeat.comAVITA Medical to Host Investor Webinar BriefingNovember 8, 2024 | globenewswire.comAVITA Medical Reports Third Quarter Financial ResultsNovember 7, 2024 | globenewswire.comAVITA Medical (RCEL) to Release Quarterly Earnings on ThursdayAVITA Medical (NASDAQ:RCEL) will be releasing earnings after the market closes on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=634876)October 31, 2024 | marketbeat.comAVITA Medical, Inc. (AVHHL)October 20, 2024 | finance.yahoo.comAQR Capital Management LLC Sells 67,535 Shares of AVITA Medical, Inc. (NASDAQ:RCEL)AQR Capital Management LLC cut its position in shares of AVITA Medical, Inc. (NASDAQ:RCEL - Free Report) by 74.5% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 23,065 shares of the company's stock afterOctober 19, 2024 | marketbeat.comEssex Investment Management Co. LLC Makes New $2.48 Million Investment in AVITA Medical, Inc. (NASDAQ:RCEL)Essex Investment Management Co. LLC bought a new stake in AVITA Medical, Inc. (NASDAQ:RCEL - Free Report) during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 231,094 shares of the company's stock, valued at approximately $2,47October 13, 2024 | marketbeat.comAVITA Medical (NASDAQ:RCEL) shareholders have endured a 74% loss from investing in the stock five years agoOctober 11, 2024 | finance.yahoo.comAVITA Medical to Announce Third Quarter 2024 Financial ResultsOctober 10, 2024 | globenewswire.comAVITA Medical to Present at 2024 Cantor Global Healthcare ConferenceSeptember 12, 2024 | globenewswire.comAVITA Medical (NASDAQ:RCEL) Stock Price Up 1.8%AVITA Medical (NASDAQ:RCEL) Stock Price Up 1.8%September 12, 2024 | marketbeat.comAVITA Medical to Participate in Lake Street’s 8th Annual Best Ideas Growth (BIG8) ConferenceSeptember 11, 2024 | markets.businessinsider.com Get AVITA Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for RCEL and its competitors with MarketBeat's FREE daily newsletter. Email Address RCEL Media Mentions By Week RCEL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RCEL News Sentiment▼0.680.46▲Average Medical News Sentiment RCEL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RCEL Articles This Week▼22▲RCEL Articles Average Week Get AVITA Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for RCEL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies National Vision News Bioventus News AxoGen News Butterfly Network News CeriBell News Iradimed News Avanos Medical News SI-BONE News OrthoPediatrics News Semler Scientific News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RCEL) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AVITA Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AVITA Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.